All Posts:nilotinib

• Vascular Defects Appear to Underlie the Progression of Parkinson’s Disease

  WASHINGTON (Friday, November 12, 2021) — In an unexpected discovery, Georgetown University Medical Center researchers have identified what appears to be a significant vascular defect in patients with moderately severe Parkinson’s disease. The finding could help explain an earlier outcome of the same study, in which the drug nilotinib was able to halt motor and […]

  Category: News Release Tags: blood-brain barrier, brain, mind, nilotinib, Parkinson's disease, research

• Nilotinib Appears Safe and Affects Biomarkers in Alzheimer’s Disease Clinical Trial

  WASHINGTON (May 29, 2020) — A Georgetown University Medical Center clinical trial investigating the cancer drug nilotinib in people with Alzheimer’s disease finds that it is safe and well-tolerated, and researchers say the drug should be tested in a larger study to further determine its safety and efficacy as a potential disease-modifying strategy. The results […]

  Category: News Release Tags: Alzheimer's disease, biomedical research, brain, brain research, clinical trials, dementia, mind, nilotinib